Gardasil Administration

Saint Louis University (SLU)

Status: Withdrawn

Conditions: Vaccine Administration Rates

Treatments: Behavioral: Appointment reminders

Study type: Interventional

Funder types: Other

Identifiers

NCT03123419

27734

Details and patient eligibility

About

The purpose of the Gardasil study is to increase the rates of Gardasil vaccination at a maternal fetal Care Center. This will be done by reminding patients via text to come for follow up vaccine appointments.

Full description

Patients will be screened in center for history of Gardasil vaccination. If the patient has not received the vaccination series they will be counseled/educated (standard of care [SOC }) and offered the vaccine series. If the patient agrees to the vaccination, they will then be offered participation in this study, (consent will be reviewed and signed) and they will receive the first vaccination at this visit, administered according to standard protocol. The patient will then be scheduled for two follow up vaccination appointments. The second vaccination will be given 2 months after the first vaccine and the third will be given 4 months after the second vaccination in accordance with the Gardasil vaccine guidelines. -SOC

The patients will receive a total of two texts during the study entirety. The two texts will be appointment reminders for the second and third vaccination, sent 1 week prior to the next appointment. This is study related.

Data collection Data will be collected using a data collection sheet. The investigators will record date of first vaccine administration and adherence to follow up.vaccinations.

Sex: Female

Ages: 9 to 26 years old

Volunteers: No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion criteria

• Patient receiving gynecological or postpartum care at the Maternal Fetal Care Center
• Females age 9-26 years per manufacturer's recommendation
• Having a cell phone that will allow texting
• Willing to accept any texting charges that may occur for receiving the reminder text.

Exclusion criteria

• Allergy to HPV-4 or HPV-9 vaccine
• Prior completion of the HPV-4/9 series,
• Pregnancy
• Patients older than 26 years old

Trial design

Primary purpose: Other

Allocation: N/A

Interventional model: Single Group Assignment

Masking: None (Open label)

---

0 participants in 1 patient group

Vaccine

Other group

Description:

All patients who consent to be in the study will receive Appointment reminders.

Treatment:

Behavioral: Appointment reminders